Phosphorylation sites of Epstein-Barr virus EBNA1 regulate its function

Journal of General Virology

Volumn 90, Issue 9, 2009, Pages 2251-2259

  Duellman, Sarah J ^a   Thompson, Katie L ^b   Coon, Joshua J ^b,c   Burgess, Richard R ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; MUTANT PROTEIN; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1;

ARTICLE; BINDING SITE; CELL NUCLEUS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HALF LIFE TIME; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RESIDUE ANALYSIS; TANDEM MASS SPECTROMETRY; TRANSCRIPTION INITIATION; WILD TYPE; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; PHOSPHORYLATION; TUMOR CELL LINE; VIROLOGY; VIRUS INFECTION;

HUMAN HERPESVIRUS 4;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVATION;

EID: 70349303509     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.012260-0     Document Type: Article

References (65)

1. Aiyar, A. & Sugden, B. (1998). Fusions between Epstein-Barr viral nuclear antigen-1 of Epstein-Barr virus and the large T-antigen of simian virus 40 replicate their cognate origins. J Biol Chem 273, 33073-33081.
2. Bergendahl, V., Glaser, B. T. & Burgess, R. R. (2003). A fast Western blot procedure improved for quantitative analysis by direct fluorescence labeling of primary antibodies. J Immunol Methods 277, 117-125.
3. Coon, J. J., Syka, J. E. P., Schwartz, J. C., Shabanowitz, J. & Hunt, D. F. (2004). Anion dependence in the partitioning between proton and electron transfer in ion/ion reactions. Int J Mass Spectrom 236, 33-42.
4. Crawford, D. H. (2001). Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356, 461-473.
5. Dhar, S. K., Yoshida, K., Machida, Y., Khaira, P., Chaudhuri, B., Wohlschlegel, J. A., Leffak, M., Yates, J. & Dutta, A. (2001). Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin. Cell 106, 287-296.
6. Duellman, S. J. & Burgess, R. R. (2006). Overproduction in Escherichia coli and purification of Epstein-Barr virus EBNA-1. Protein Expr Purif 47, 434-440.
7. Duellman, S. J. & Burgess, R. R. (2009). Antigen-binding properties of monoclonal antibodies reactive with EBNA1 and use in immunoaffinity chromatography. PLoS One 4, e4614.
8. Fahraeus, R. (2005). Do peptides control their own birth and death? Nat Rev Mol Cell Biol 6, 263-267.
9. Frappier, L. & O'Donnell, M. (1991a). Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc Natl Acad Sci U S A 88, 10875-10879.
10. Frappier, L. & O'Donnell, M. (1991b). Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus. J Biol Chem 266, 7819-7826.
11. Freire, E., Oddo, C., Frappier, L. & de Prat-Gay, G. (2008). Kinetically driven refolding of the hyperstable EBNA1 origin DNA-binding dimeric β-barrel domain into amyloid-like spherical oligomers. Proteins 70, 450-461.
12. Gahn, T. A. & Sugden, B. (1995). An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J Virol 69, 2633-2636.
13. Geer, L. Y., Markey, S. P., Kowalak, J. A., Wagner, L., Xu, M., Maynard, D. M., Yang, X., Shi, W. & Bryant, S. H. (2004). Open mass spectrometry search algorithm. J Proteome Res 3, 958-964.
14. Goldsmith, K., Bendell, L. & Frappier, L. (1993). Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication. J Virol 67, 3418-3426.
15. Good, D. M., Wirtala, M., McAlister, G. C. & Coon, J. J. (2007). Performance characteristics of electron transfer dissociation mass spectrometry. Mol Cell Proteomics 6, 1942-1951.
16. Hearing, J. C. & Levine, A. J. (1985). The Epstein-Barr virus nuclear antigen (BamHI K antigen) is a single-stranded DNA binding phosphoprotein. Virology 145, 105-116.
17. Hietakangas, V., Anckar, J., Blomster, H. A., Fujimoto, M., Palvimo, J. J., Nakai, A. & Sistonen, L. (2006). PDSM, a motif for phosphorylation-dependent SUMO modification. Proc Natl Acad Sci U S A 103, 45-50.
18. Ito, S., Ikeda, M., Kato, N., Matsumoto, A., Ishikawa, Y., Kumakubo, S. & Yanagi, K. (2000). Epstein-Barr virus nuclear antigen-1 binds to nuclear transporter karyopherin α1/NPI-1 in addition to karyopherin α2/Rch1. Virology 266, 110-119.
19. Kennedy, G. & Sugden, B. (2003). EBNA-1, a bifunctional transcriptional activator. Mol Cell Biol 23, 6901-6908.
20. Kennedy, G., Komano, J. & Sugden, B. (2003). Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc Natl Acad Sci U S A 100, 14269-14274.
21. Kim, A. L., Maher, M., Hayman, J. B., Ozer, J., Zerby, D., Yates, J. L. & Lieberman, P. M. (1997). An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin α. Virology 239, 340-351.
22. Kitamura, R., Sekimoto, T., Ito, S., Harada, S., Yamagata, H., Masai, H., Yoneda, Y. & Yanagi, K. (2006). Nuclear import of Epstein-Barr virus nuclear antigen 1 mediated by NPI-1 (importin α5) is up- and down-regulated by phosphorylation of the nuclear localization signal for which Lys379 and Arg380 are essential. J Virol 80, 1979-1991.
23. Lee, D. Y. & Sugden, B. (2008). The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis. Blood 111, 2280-2289.
24. Lee, M. A., Diamond, M. E. & Yates, J. L. (1999). Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. J Virol 73, 2974-2982.
25. Leight, E. R. & Sugden, B. (2000). EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev Med Virol 10, 83-100.
26. Leight, E. R. & Sugden, B. (2001). Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol 21, 4149-4161.
27. Levitskaya, J., Sharipo, A., Leonchiks, A., Ciechanover, A. & Masucci, M. G. (1997). Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci U S A 94, 12616-12621.
28. crystallin complex. Mol Cell 24, 355-366.
29. Lindner, S. E., Zeller, K., Schepers, A. & Sugden, B. (2008). The affinity of EBNA1 for its origin of DNA synthesis is a determinant of the origin's replicative efficiency. J Virol 82, 5693-5702.
30. Lu, K. P., Liou, Y. C. & Zhou, X. Z. (2002). Pinning down proline-directed phosphorylation signaling. Trends Cell Biol 12, 164-172.
31. Lusky, M. & Fontane, E. (1991). Formation of the complex of bovine papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and depends upon sequences within the carboxyl terminus of E1. Proc Natl Acad Sci U S A 88, 6363-6367.
32. Mackey, D. & Sugden, B. (1999). The linking regions of EBNA1 are essential for its support of replication and transcription. Mol Cell Biol 19, 3349-3359.
33. Mackey, D., Middleton, T. & Sugden, B. (1995). Multiple regions within EBNA1 can link DNAs. J Virol 69, 6199-6208.
34. Martin, S. E., Shabanowitz, J., Hunt, D. F. & Marto, J. A. (2000). Subfemtomole MS and MS/MS peptide sequence analysis using nano-HPLC micro-ESI Fourier transform ion cyclotron resonance mass spectrometry. Anal Chem 72, 4266-4274.
35. McAlister, G. C., Phanstiel, D., Good, D.M., Berggren,W. T. & Coon, J. J. (2007). Implementation of electron-transfer dissociation on a hybrid linear ion trap-orbitrap mass spectrometer. Anal Chem 79, 3525-3534.
36. McAlister, G. C., Berggren, W. T., Griep-Raming, J., Horning, S., Makarov, A., Phanstiel, D., Stafford, G., Swaney, D. L., Syka, J. E. & other authors (2008). A proteomics grade electron transfer dissociation-enabled hybrid linear ion trap-orbitrap mass spectrometer. J Proteome Res 7, 3127-3136.
37. McBride, A. A. & Howley, P. M. (1991). Bovine papillomavirus with a mutation in the E2 serine 301 phosphorylation site replicates at a high copy number. J Virol 65, 6528-6534.
38. McBride, A. A., Bolen, J. B. & Howley, P. M. (1989). Phosphorylation sites of the E2 transcriptional regulatory proteins of bovine papillomavirus type 1. J Virol 63, 5076-5085.
39. Menezes, J., Leibold, W., Klein, G. & Clements, G. (1975). Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine 22, 276-284.
40. Middleton, T. & Sugden, B. (1992). EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication. J Virol 66, 489-495.
41. Munz, C. (2004). Epstein-Barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target. J Exp Med 199, 1301-1304.
42. Ndassa, Y. M., Orsi, C., Marto, J. A., Chen, S. & Ross, M. M. (2006). Improved immobilized metal affinity chromatography for large-scale phosphoproteomics applications. J Proteome Res 5, 2789-2799.
43. Ohara, N., Hayashi, K., Teramoto, N., Oka, T., Fujimoto, K., Yoshikawa, Y., Castanos-Velez, E., Biberfeld, P. & Akagi, T. (2000). Sequence analysis and variation of EBNA-1 in Epstein-Barr virus-related herpesvirus of cynomolgus monkey. Intervirology 43, 102-106.
44. Polvino-Bodnar, M., Kiso, J. & Schaffer, P. A. (1988). Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1). Nucleic Acids Res 16, 3415-3435.
45. Ritzi, M., Tillack, K., Gerhardt, J., Ott, E., Humme, S., Kremmer, E., Hammerschmidt, W. & Schepers, A. (2003). Complex protein-DNA dynamics at the latent origin of DNA replication of Epstein-Barr virus. J Cell Sci 116, 3971-3984.
46. Roscic, A., Moller, A., Calzado, M. A., Renner, F., Wimmer, V. C., Gresko, E., Ludi, K. S. & Schmitz, M. L. (2006). Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol Cell 24, 77-89.
47. Shah, W. A., Ambinder, R. F., Hayward, G. S. & Hayward, S. D. (1992). Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions. J Virol 66, 3355-3362.
48. Shire, K., Kapoor, P., Jiang, K., Hing, M. N., Sivachandran, N., Nguyen, T. & Frappier, L. (2006). Regulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylation. J Virol 80, 5261-5272.
49. Su, W., Middleton, T., Sugden, B. & Echols, H. (1991). DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1. Proc Natl Acad Sci U S A 88, 10870-10874.
50. Sugden, B. & Warren, N. (1989). A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J Virol 63, 2644-2649.
51. Swaney, D. L., McAlister, G. C., Wirtala, M., Schwartz, J. C., Syka, J. E. & Coon, J. J. (2007). Supplemental activation method for high-efficiency electron-transfer dissociation of doubly protonated peptide precursors. Anal Chem 79, 477-485.
52. Syka, J. E., Coon, J. J., Schroeder, M. J., Shabanowitz, J. & Hunt, D. F. (2004). Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci U S A 101, 9528-9533.
53. + T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1. J Exp Med 199, 1421-1431.
54. Thompson, N. E., Hager, D. A. & Burgess, R. R. (1992). Isolation and characterization of a polyol-responsive monoclonal antibody useful for gentle purification of Escherichia coli RNA polymerase. Biochemistry 31, 7003-7008.
55. Wang, C. Y. & Sugden, B. (2008). Identifying a property of origins of DNA synthesis required to support plasmids stably in human cells. Proc Natl Acad Sci U S A 105, 9639-9644.
56. Wang, J., Lindner, S. E., Leight, E. R. & Sugden, B. (2006). Essential elements of a licensed, mammalian plasmid origin of DNA synthesis. Mol Cell Biol 26, 1124-1134.
57. Williams, D. K., Jr, McAlister, G. C., Good, D. M., Coon, J. J. & Muddiman, D. C. (2007). Dual electrospray ion source for electron-transfer dissociation on a hybrid linear ion trap-orbitrap mass spectrometer. Anal Chem 79, 7916-7919.
58. Wu, H., Kapoor, P. & Frappier, L. (2002). Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J Virol 76, 2480-2490.
59. Yates, J. L. & Camiolo, S. M. (1988). Dissection of DNA replication and enhancer activation functions of Epstein-Barr virus nuclear antigen 1. Cancer Cells 6, 197-205.
60. Yates, J., Warren, N., Reisman, D. & Sugden, B. (1984). A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A 81, 3806-3810.
61. Yates, J. L., Warren, N. & Sugden, B. (1985). Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812-815.
62. Yates, J. L., Camiolo, S. M., Ali, S. & Ying, A. (1996). Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology 222, 1-13.
63. Yin, Y., Manoury, B. & Fahraeus, R. (2003). Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 301, 1371-1374.
64. Young, L. S. & Rickinson, A. B. (2004). Epstein-Barr virus: 40 years on. Nat Rev Cancer 4, 757-768.
65. Yu, X., Fu, S., Lai, M., Baer, R. & Chen, J. (2006). BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP. Genes Dev 20, 1721-1726.